Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/56744
Title: | Factors Associated with Increasing Costs in Severe Chronic Obstructive Pulmonary Disease Exacerbation: Turkish Thoracic Society Chronic Obstructive Pulmonary Disease Assembly | Authors: | Baha, A. Köktürk, N. Baysan, C. Öztürk, B. Cengiz, S.K. Varol, Y. Mertoğlu, A. Çırak, Ali Kadri Turan, Onur Dursunoğlu, Neşe Savurmuş, Nilufer Gürgün, Alev Elmas, Funda Çöplü, Lütfi Sertçelik, Ümran Yıldız, Reyhan Özmen, İpek Alpaydın, Aylin Özgen |
Keywords: | antibiotic COPD costs discharge nutrition pulmonary rehabilitation severe exacerbation hemoglobin A1c adult aged antibiotic resistance Article artificial ventilation body mass bronchoscopy cause of death chronic obstructive lung disease computed tomographic angiography cost effectiveness analysis disease exacerbation echocardiography female follow up forced expiratory volume hospital mortality hospitalization hospitalization cost human intensive care unit length of stay lung function test major clinical study male multicenter study observational study oxidative stress oxygen consumption parenteral nutrition passive smoking percutaneous nephrolithotomy physiotherapy prospective study pulmonary rehabilitation questionnaire risk assessment social status thorax radiography Turk (people) vaccination |
Publisher: | AVES | Abstract: | OBJECTIVE: Chronic obstructive pulmonary disease (COPD) that is the third leading cause of death in the world is one of the main economic burden. The cost is primarily due to COPD exacerbations and hospitalizations. We aimed to determine the factors associated with increasing costs in severe COPD exacerbation. MATERIAL AND METHODS: It was a multicenter and prospective observational recording study. 294 patients who severe COPD exacerbation were included in the study. An amount of more than 429.58 euros was accepted as increasing costs (IC). Factors associated with IC were determined by regression analysis. RESULTS: Mean age was 69.90 ± 9.79/years (minimum: 40 maximum: 95), mean costs were 594.9 ± 70.9 euros. About 83.7% of the patients were male, 24.1% (71) were active smokers, and 81% (238) had at least 1 comorbidity. Factors associated with IC in the regression analysis were delay of discharge (due to prolonged consultation), antibiotic use longer than 7 days, need to enteral/parenteral feeding, application of pulmonary rehabilitation (physiotherapy) at hospitalization, and refusal to be discharged. CONCLUSION: The increasing costs in severe COPD exacerbation depends not only treatment but also the patient’s social status and hospital-related factors. We think that the cost of severe COPD exacerbation can be reduced by interventions on interchangeable factors such as patient's social status and hospital-related factors. © Author(s). | URI: | https://doi.org/10.5152/ThoracResPract.2024.23065 https://hdl.handle.net/11499/56744 |
ISSN: | 2979-9139 |
Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
CORE Recommender
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.